期刊文献+

度洛西汀联合奥氮平致高脂肪酶血症1例 被引量:3

One case of Duloxetine combined with Olanzapine induced hyperlipasaemia
下载PDF
导出
摘要 本文通过对1例高脂肪酶血症患者血浆脂肪酶含量和度洛西汀联合奥氮平药物浓度的相关性分析,发现脂肪酶含量随着药物浓度的升高而逐渐上升,提示这两种药物的使用可能致血浆脂肪酶水平升高。 To analyze the lipase level and drug concentration of duloxetine combined with olanzapine in the plasma of one patient with hyperlipasaemia, correlation analysis found that lipase level gradually increased with the increase of drug concentration, suggesting that the application of these two drugs in patients can cause elevated levels of plasma lipase.
出处 《胃肠病学和肝病学杂志》 CAS 2013年第1期24-24,27,共2页 Chinese Journal of Gastroenterology and Hepatology
关键词 高脂肪酶血症 度洛西汀 奥氮平 药物浓度 抑郁 Hyperlipasaemia Duloxetine Olanzapine Drug concentration Depressed
  • 相关文献

参考文献2

  • 1国效峰,赵靖平,陈晋东.度洛西汀:一种新型抗抑郁药[J].中国新药与临床杂志,2006,25(7):552-555. 被引量:89
  • 2Fulton B,Goa KL. Olanzapine,a review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses[J].Drugs,1997,(02):281.

二级参考文献26

  • 1温新民,毛庆华,汤建,虞心红.度洛西汀的合成进展[J].合成化学,2004,12(6):551-554. 被引量:11
  • 2WERNICKE JF, ROSEN A, LU Y, et al. The safety of duloxetine in the long-term treatment of diabetic neuropathic pain (C).Presented at the Collegium Internationale Neuropsychopharmacologicum, Paris, June 2004.
  • 3GREIST J, MCNAMARA RK, MALLINCKRODT CH, et al. Incidence and duration of antidepressant-induced nausea:duloxetine compared with paroxetine and fluoxetine[J]. Clin Ther,2004,26(9) : 1446-1455.
  • 4WERNICKE JF, GAHIMER J, YALCIN I, et al. Safety and adverse event profile of duloxetine[J]. Expert Opin Drug Saf, 2005,4(6) :987-993.
  • 5THASE ME, TRAN PV, WILTSE C, et al. Cardiovascular profile of duloxetine,a dual reuptake inhibitor of serotonin and norepinephrine[J]. J Clin Psychopharmacol, 2005,25 (2) : 132-140.
  • 6SKINNER MH, KUAN HY, PAN A, et al. Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers[J]. Clin Pharmacol Ther, 2003,73(3):170-177.
  • 7ANATHEA BW, PETER K. Duloxetine hydrochloride[J]. Nature Reviews, 2004,3 ( 11 ) : 907- 908.
  • 8CRUZ MP, GONZALES ME, JACOBS J, et al. Duloxetine HCI(Cymbalta) for the treatment of depression, neuropathic pain,fibromyalgia, and stress urinary incontinence[J]. Drug Forecast,2006, 31 (2) :84-97.
  • 9BYMASTER FP, DRESHFELD-AHMAD LJ, THRELKELD PG,et al. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo,human serotonin receptor subtypes, and other neuronal receptors[J]. Neuropsychophannacology, 2001, 25 (6) : 871-880.
  • 10WESTANMO AD, GAYKEN J, HAIGHT R. Duloxetine: a balanced and selective norepinephrine-and serotonin-reuptake inhibitor[J]. Am J Health Syst Pharm, 2005,62(23) :2481-2490.

共引文献88

同被引文献52

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部